Effect of orexin-a on ischemia-reperfusion-induced gastric damage in rats

Journal of Gastroenterology

Volumn 43, Issue 3, 2008, Pages 202-207

  Bülbül, Mehmet ^a   Tan, Ruken ^a   Gemici, Burcu ^a   Öngüt, Gözde ^a   Izgüt Uysal, V Nimet ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Ischemia reperfusion; Mucus; Myeloperoxidase; Orexin A; ProstaglandinE2

Indexed keywords

MYELOPEROXIDASE; OREXIN A; PROSTAGLANDIN E2; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; ISCHEMIA; LEUKOCYTE ACTIVATION; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; STOMACH INJURY; STOMACH MUCOSA; STOMACH MUCUS; STOMACH PROTECTION;

ANIMALS; DINOPROSTONE; FEMALE; GASTRIC MUCOSA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPID PEROXIDATION; MUCUS; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; NEUTROPHIL ACTIVATION; PEROXIDASE; RATS; RATS, WISTAR; REPERFUSION INJURY; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 41749120775     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-007-2148-3     Document Type: Article

References (37)

1. Okumura T, Takeuchi S, Motomura W, Yamada H, Egashira Si S, Asahi S, et al. Requirement of intact disulfide bonds in orexin A-induced stimulation of gastric acid secretion that is mediated by OX1 receptor activation. Biochem Biophys Res Commun 2001;280:976-981.
2. Ehrstrom M, Gustafsson T, Finn A, Kirchgessner A, Gryback P, Jacobsson H, et al. Inhibitory effect of exogenous orexin a on gastric emptying, plasma leptin, and the distribution of orexin and orexin receptors in the gut and pancreas in man. J Clin Endocrinol Metab 2005;90:2370-2377.
3. Naslund E, Ehrstrom M, Ma J, Hellstrom PM, Kirchgessner AL. Localization and effects of orexin on fasting motility in the rat duodenum. Am J Physiol Gastrointest Liver Physiol 2002;282:470-479.
4. Kirchgessner AL. Orexins in the brain-gut axis. Endocr Rev 2002;23:1-15.
5. Johren O, Neidert SJ, Kummer M, Dendorfer A, Dominiak P. Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology 2001;142:3324-3331.
6. Yan GT, Lin J, Liao J. Distribution of orexin-A mRNA expression in different organs and its variation in acute inflammation. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2005;17:207-210.
7. Satoh Y, Uchida M, Fujita A, Nishio H, Takeuchi T, Hata F. Possible role of orexin A in nonadrenergic, noncholinergic inhibitory response of muscle of the mouse small intestine. Eur J Pharmacol 2001;428:337-342.
8. Kobashi M, Furudono Y, Matsuo R, Yamamoto T. Central orexin facilitates gastric relaxation and contractility in rats. Neurosci Lett 2002;332:171-174.
9. Ehrstrom M, Levin F, Kirchgessner AL, Schmidt PT, Hilsted LM, Gryback P, et al. Stimulatory effect of endogenous orexin A on gastric emptying and acid secretion independent of gastrin. Regul Pept 2005;132:9-16.
10. Konturek PC, Brzozowski T, Walter B, Burnat G, Hess T, Hahn EG, et al. Ghrelin-induced gastroprotection against ischemia-reperfusion injury involves an activation of sensory afferent nerves and hyperemia mediated by nitric oxide. Eur J Pharmacol 2006;536:171-181.
11. Nejadkey F, Nahavandi A, Dehpour AR, Mani AR. Role of nitric oxide in the gastro-protective effect of lithium. Pathophysiology 2006;13:85-89.
12. Brzozowski T, Konturek PC, Konturek SJ, Brzozowska I, Pawlik T. Role of prostaglandins in gastroprotection and gastric adaptation. J Physiol Pharmacol 2005;56:33-55.
13. Sanchez S, Martin MJ, Ortiz P, Motilva V, Herrerias JM, Alarcon de Lastra C. Role of prostaglandins and nitric oxide in gastric damage induced by metamizol in rats. Inflamm Res 2002;51:385-392.
14. Derin N, Agac A, Bayram Z, Asar M, Izgut-Uysal VN. Effects of L-carnitine on neutrophil-mediated ischemia-reperfusion injury in rat stomach. Cell Biochem Funct 2006;24:437-442.
15. De La Lastra CA, Cabeza J, Motilva V, Martin MJ. Melatonin protects against gastric ischemia-reperfusion injury in rats. J Pineal Res 1997;23:47-52.
16. Villegas I, Martin AR, Toma W, de la Lastra CA. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: Role of oxygen free radicals generation. Eur J Pharmacol 2004;505:195-203.
17. Silen W, Schiessel R, Kivilaakso E. The gastric mucosal barrier and ulceration. Brain Res Bull 1980;5:3-6.
18. Yoshikawa T, Takahashi S, Naito Y, Ueda S, Tanigawa T, Yoshida N, et al. Effects of a platelet-activating factor antagonist, CV-6209, on gastric mucosal lesions induced by ischemia-reperfusion. Lipids 1992;27:1058-1060.
19. Wada K, Kamisaki Y, Kitano M, Kishimoto Y, Nakamoto K, Itoh T. A new gastric ulcer model induced by ischemia-reperfusion in the rat: Role of leukocytes on ulceration in rat stomach. Life Sci 1996;59:295-301.
20. Dohi K, Ripley B, Fujiki N, Ohtaki H, Shioda S, Aruga T, et al. CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH). Peptides 2005;26:2339-2343.
21. Irving EA, Harrison DC, Babbs AJ, Mayes AC, Campbell CA, Hunter AJ, et al. Increased cortical expression of the orexin-1 receptor following permanent middle cerebral artery occlusion in the rat. Neurosci Lett 2002;324:53-56.
22. Corne S, Marrissey SM, Woods RJ. A method for quantitative estimation of gastric barrier mucus. J Physiol (Lond) 1974;242:1169-1179.
23. Stocks J, Offerman EL, Modell CB, Dormandy TL. The susceptibility to autooxidation of human red cell lipids in health and disease. British J Haematol 1972;23:713-724.
24. Murakami K, Okajima K, Uchiba M, Harada N, Liu W, Okabe H, et al. Role of granulocyte elastase in indomethacin-induced gastric mucosal lesion formation in rats. J Lab Clin Med 1997;130:307-313.
25. Nakamachi T, Endo S, Ohtaki H, Yin L, Kenji D, Kudo Y, et al. Orexin-1 receptor expression after global ischemia in mice. Regul Pept 2005;126:49-54.
26. Lin J, Yan GT, Gao XN, Liao J, Hao XH, Zhang K. Effect of intestinal ischemia/reperfusion injury on leptin and orexin-A levels. Nan Fang Yi Ke Da Xue Xue Bao 2006;26:719-724.
27. Mojzis J, Hegedusova R, Mirossay L. Role of mucus in ischemia/ reperfusion-induced gastric mucosal injury in rats. Physiol Res 2000;49:441-446.
28. Mojzis J, Hviscova K, Germanova D, Bukovicova D, Mirossay L. Protective effect of quercetin on ischemia/reperfusion-induced gastric mucosal injury in rats. Physiol Res 2001;50:501-506.
29. Derin N, Izgut-Uysal VN, Agac A, Aliciguzel Y, Demir N. L-carnitine protects gastric mucosa by decreasing ischemia-reperfusion induced lipid peroxidation. J Physiol Pharmacol 2004;55:595-606.
30. Qiao WL, Wang L, Zhang JF, Zhang YM. Effects of gastric ischemia-reperfusion on gastric mucosal cellular apoptosis and proliferation in rats. Sheng Li Xue Bao 2006;58:237-243.
31. Zhang LH, Yao CB, Gao MQ, Li HQ. Gastric mucosal injury due to hemorrhagic reperfusion and efficacy of Salvia miltiorrhizae extract F and cimetidine. World J Gastroenterol 2005;11:2830-2833.
32. Peskar BM. Role of cyclooxygenase isoforms in gastric mucosal defense and ulcer healing. Inflammopharmacology 2005;13:15-26.
33. Pajdo R, Brzozowski T, Konturek PC, Kwiecien S, Konturek SJ, Sliwowski Z, et al. Ischemic preconditioning, the most effective gastroprotective intervention: Involvement of prostaglandins, nitric oxide, adenosine and sensory nerves. Eur J Pharmacol 2001;427:263-276.
34. Monda M, Viggiano A, Mondola P, De Luca V. Inhibition of prostaglandin synthesis reduces hyperthermic reactions induced by hypocretin-1/orexin A. Brain Res 2001;909:68-74.
35. Kitano M, Wada K, Kamisaki Y, Nakamoto K, Kishimoto Y, Kawasaki H, et al. Effects of cimetidine on acute gastric mucosal injury induced by ischemia-reperfusion in rats. Pharmacology 1997;55:154-164.
36. Brzozowski T, Konturek PC, Sliwowski Z, Pajdo R, Drozdowicz D, Kwiecien S, et al. Prostaglandin/cyclooxygenase pathway in ghrelin-induced gastroprotection against ischemia-reperfusion injury. J Pharmacol Exp Ther 2006;319:477-487.
37. Skibska B, Jozefowicz-Okonkwo G, Goraca A. Protective effects of early administration of alpha-lipoic acid against lipopolysaccharide-induced plasma lipid peroxidation. Pharmacol Rep 2006;58:399-404.